Furthermore, lower ACTN4 expression was associated with significantly worse overall survival in HNSCC patients (Supplementary Fig. 1J-L), suggesting that ACTN4 may exert a tumor-suppressive role in HNSCC. This evidence concerns the gene ACTN4 and head and neck squamous cell carcinoma.